The coronary stent market, valued at USD 8.99 billion in 2023, is expected to reach USD 12.51 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.

Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5152

Key Market Insights

• Dominant Product Segment: Drug-eluting stents (DES) held a 60% market share in 2023.
• Regional Market Leader: North America led the market with a 37% share in 2023.
• Fastest-Growing Segment: Bioresorbable Scaffold Systems (BRS) are projected to grow at a 5.2% CAGR during the forecast period.

Market Drivers and Trends

• Rising Coronary Artery Disease (CAD) Incidence: The global burden of CAD, a leading cause of death, is driving demand for coronary stents. CAD is characterized by the accumulation of plaque in coronary arteries, restricting blood flow and causing conditions like chest pain, heart attacks, and heart failure.
• Minimally Invasive Treatments Preferred: Patients and healthcare providers increasingly prefer percutaneous coronary intervention (PCI), a less invasive method that involves placing a coronary stent via catheter, due to its shorter recovery time, reduced pain, and shorter hospital stays compared to traditional bypass surgery.
• Technological Advancements:
  • Drug-Eluting Stents (DES): Designed to prevent restenosis by releasing medication to inhibit cell proliferation.
  • Biocompatible Coatings: Reduces inflammation and risk of thrombosis.
  • Flexible Stent Designs: Improved adaptability to various vessel shapes and diameters.
• Cost-Effectiveness Focus: Efforts are ongoing to balance patient care with cost management. Strategies include promoting generic stents, implementing value-based pricing, negotiating bulk purchase agreements, and optimizing patient selection and procedural efficiencies.

Geographic Market Analysis

• North America: Leading the global coronary stent market due to the high prevalence of CAD, advanced healthcare infrastructure, and comprehensive insurance coverage for stenting procedures.
• Europe: A mature market characterized by strict regulations and a focus on cost-effectiveness. European companies are heavily involved in developing innovative stent technologies.
• Asia-Pacific: Expected to see significant growth due to an increasing prevalence of CAD, improving healthcare infrastructure, and rising awareness of minimally invasive treatment options.

Future Market Outlook

The coronary stent market is poised for continued growth driven by technological advancements, an increasing aging population, and rising rates of diabetes and other lifestyle-related diseases. Innovations in stent design and materials, coupled with a demand for minimally invasive procedures, are expected to further propel market expansion.